Drug intelligence / Profile preview

Meocil

Development stage
Unknown
Lead developer
Laboratório EDOL Produtos Farmacêuticos
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Meocil is a fixed-dose combination ophthalmic ointment developed by Laboratório EDOL. It contains three active ingredients: prednisolone acetate (a synthetic corticosteroid), neomycin sulfate (an aminoglycoside antibiotic), and sulfacetamide sodium (a sulfonamide antibacterial). This combination provides dual anti-inflammatory and antibacterial action, making it highly effective for treating inflammatory ocular conditions where a bacterial infection is present or suspected, such as blepharitis, conjunctivitis, and other infectious and inflammatory eye disorders.

Brand names
Meocil
Other names
acetato de prednisolona + sulfato de neomicina + sulfacetamida sódicaprednisolone acetate + neomycin sulfate + sulfacetamide sodiumprednisolone acetate/neomycin sulfate/sulfacetamide sodium
02

Targets

Bacterial RibosomeDHPS (Dihydropteroate synthase)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Meocil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meocil.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call